0 20

Cited 0 times in

Cited 0 times in

Response to the Letter to the Editor: "Lazertinib in EGFR-Mutated NSCLC with CNS Metastases: Reinforcing the Role of Third-Generation TKIs through Pooled Analysis

DC Field Value Language
dc.contributor.authorCho, Byoung Chul-
dc.contributor.authorKim, YuKyung-
dc.date.accessioned2026-03-11T01:38:06Z-
dc.date.available2026-03-11T01:38:06Z-
dc.date.created2026-01-28-
dc.date.issued2026-01-
dc.identifier.issn1525-7304-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/211130-
dc.language영어-
dc.publisherCIG MEDIA GROUP, LP-
dc.relation.isPartOfCLINICAL LUNG CANCER-
dc.titleResponse to the Letter to the Editor: "Lazertinib in EGFR-Mutated NSCLC with CNS Metastases: Reinforcing the Role of Third-Generation TKIs through Pooled Analysis-
dc.typeArticle-
dc.contributor.googleauthorCho, Byoung Chul-
dc.contributor.googleauthorKim, YuKyung-
dc.identifier.doi10.1016/j.clc.2025.11.013-
dc.identifier.pmid41364949-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S1525730425003213-
dc.contributor.affiliatedAuthorCho, Byoung Chul-
dc.identifier.scopusid2-s2.0-105024102268-
dc.identifier.wosid001638562700001-
dc.citation.volume27-
dc.citation.number1-
dc.citation.startPage72-
dc.citation.endPage73-
dc.identifier.bibliographicCitationCLINICAL LUNG CANCER, Vol.27(1) : 72-73, 2026-01-
dc.identifier.rimsid91311-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.type.docTypeLetter-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryOncology-
dc.relation.journalResearchAreaOncology-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.